PalBociclib Impurity 23 Chemical Properties

Boiling point:

694.5±65.0 °C(Predicted)

Density 

1.313±0.06 g/cm3(Predicted)

pka

8.63±0.10(Predicted)

PalBociclib Impurity 23 Usage And Synthesis

Uses

Palbociclib Impurity A is related to the parent compound, Palbocicib (P139900) (also known as compound number PD-0332991), which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.Also, it is derived from 3-Fluoro-2-nitropyridine (F597685).

PalBociclib Impurity 23(2205035-04-5)Related Product Information

• 6-broMo-8-cyclopentyl-5-Methyl-2-(5-(piperazin-1-yl)pyridin-2-ylaMino)pyrido[2,3-d]pyriMidin-7(8H)-one
• Palbociclib Impurity 15
• PalBociclib Impurity 24
• PalBociclib Impurity 17
• Pyrido[2,3-d]pyriMidin-7(8H)-one, 2,6-dibroMo-8-cyclopentyl-5-Methyl-
• Palbociclib-012
• 2-chloro-4-(cyclopentylamino)-5-pyrimidinyl ethanone
• PalBociclib Impurity 25
• PalBociclib Impurity 14
• Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-
• 8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-6-vinylpyrido[2,3-d]pyrimidin-7(8H)-one
• Palbociclib
• (ACETYLMETHYLENE)TRIPHENYLPHOSPHORANE
• tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
• Palbociclib Impurity 21
• Palbociclib Impurity 12
• PalBociclib Impurity 18
• PalBociclib Impurity 11